Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Shunfeng Biotechnology is a Chinese animal health company that specializes in the development, manufacturing, and sale of veterinary medicines and nutritional additives. Established in 2003 and headquartered in Nanchang, the company operates state-of-the-art GMP-certified facilities to produce a variety of dosage forms, including injections, oral solutions, and soluble powders. Its products are designed to improve the health and productivity of livestock and poultry, specifically targeting swine and avian species. The company is a recognized player in the regional agricultural sector, contributing to animal disease prevention and control through its extensive portfolio of anti-infectives and growth-promoting supplements. Jiangxi Shunfeng Biotechnology serves the domestic Chinese agricultural market, positioning itself as a key provider of integrated health solutions for large-scale farming operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Shunfeng Biotechnology.